Emerging advances and future opportunities in the molecular and therapeutic landscape of anal cancer.
Saved in:
| Title: | Emerging advances and future opportunities in the molecular and therapeutic landscape of anal cancer. |
|---|---|
| Authors: | Rödel F; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany., Fleischmann M; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany., Diefenhardt M; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany., Dapper H; Department of Radiation Oncology, Cyberknife and Radiotherapy, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany., Hoffmann A; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt, Germany., Rödel C; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany., Martin D; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany., Fokas E; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt, Germany. emmanouil.fokas@uk-koeln.de.; German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany. emmanouil.fokas@uk-koeln.de.; Department of Radiation Oncology, Cyberknife and Radiotherapy, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany. emmanouil.fokas@uk-koeln.de. |
| Source: | Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2025 Jul; Vol. 22 (7), pp. 483-498. Date of Electronic Publication: 2025 May 13. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500077 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1759-4782 (Electronic) Linking ISSN: 17594774 NLM ISO Abbreviation: Nat Rev Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40360682 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Emerging advances and future opportunities in the molecular and therapeutic landscape of anal cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Rödel+F%22">Rödel F</searchLink>; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Fleischmann+M%22">Fleischmann M</searchLink>; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Diefenhardt+M%22">Diefenhardt M</searchLink>; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Dapper+H%22">Dapper H</searchLink>; Department of Radiation Oncology, Cyberknife and Radiotherapy, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Hoffmann+A%22">Hoffmann A</searchLink>; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Rödel+C%22">Rödel C</searchLink>; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Martin+D%22">Martin D</searchLink>; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Fokas+E%22">Fokas E</searchLink>; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt, Germany. emmanouil.fokas@uk-koeln.de.; German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany. emmanouil.fokas@uk-koeln.de.; Department of Radiation Oncology, Cyberknife and Radiotherapy, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany. emmanouil.fokas@uk-koeln.de. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101500077%22">Nature reviews. Clinical oncology</searchLink> [Nat Rev Clin Oncol] 2025 Jul; Vol. 22 (7), pp. 483-498. <i>Date of Electronic Publication: </i>2025 May 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101500077 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1759-4782 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217594774%22">17594774 </searchLink><i>NLM ISO Abbreviation: </i>Nat Rev Clin Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40360682 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41571-025-01025-x Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 483 Titles: – TitleFull: Emerging advances and future opportunities in the molecular and therapeutic landscape of anal cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Rödel F – PersonEntity: Name: NameFull: Fleischmann M – PersonEntity: Name: NameFull: Diefenhardt M – PersonEntity: Name: NameFull: Dapper H – PersonEntity: Name: NameFull: Hoffmann A – PersonEntity: Name: NameFull: Rödel C – PersonEntity: Name: NameFull: Martin D – PersonEntity: Name: NameFull: Fokas E IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2025 Jul Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1759-4782 Numbering: – Type: volume Value: 22 – Type: issue Value: 7 Titles: – TitleFull: Nature reviews. Clinical oncology Type: main |
| ResultId | 1 |